Crossmark

Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia

Crossref DOI link: https://doi.org/10.1186/s12866-019-1482-y

Published Online: 2019-05-23

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ceballos-Garzón, Andrés

Cortes, Gloria

Morio, Florent

Zamora-Cruz, Edna L.

Linares, Melva Y.

Ariza, Beatriz E.

Valderrama, Sandra L.

Garzón, Javier R.

Alvarez-Moreno, Carlos A.

Le Pape, Patrice

Parra-Giraldo, Claudia M. https://orcid.org/0000-0003-1302-5429
Funding

Funding for this research was provided by:

Hospital Universitario de San Ignacio (2014-52)

Pontificia Universidad Javeriana (7710)
License Information

Text and Data Mining valid from 2019-05-23

Version of Record valid from 2019-05-23
More Information

Article History

Received: 26 November 2018

Accepted: 7 May 2019

First Online: 23 May 2019

Ethics approval and consent to participate

: The research and ethics committee of the Hospital Universitario San Ignacio (HUSI) approved this study (no. FM-CIE-8053-14). All patients are anonymized and only the code of isolates were transferred for this investigation. Therefore, no informed consent was required.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below